Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs

Abstract Glioblastoma multiforme continues to be one of the most aggressive brain cancers, posing a serious health challenge, as it offers a median survival of only 15–23 months and a 5-year survival rate of less than 6%. Current treatments often prove inadequate, underscoring the urgency for new th...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hamzeh J. Al-Ameer, Malek Zihlif, Ahmed Maslat, Wajdy J. Al-Awaida, Amani Marwan Ayyash, Amer Imraish, Nidal Al-Qinna, Tareq Al-Omari, Talal Al-Qaisi, Walid Al-Zyoud, Bayan T. Alzubi, Ali M. Atoom, Isam A. Fattash, Shubhankar Ambike, Khang Wen Goh, Yulia Sh. Gushchina
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2025-07-01
Edice:	Scientific Reports
Témata:	Glioblastoma siRNA PFKFB4 HMOX1 Doxorubicin Temozolomide
On-line přístup:	https://doi.org/10.1038/s41598-025-97192-z
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!